These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3801770)

  • 1. High affinity binding of [3H]-tyramine in the central nervous system.
    Vaccari A
    Br J Pharmacol; 1986 Sep; 89(1):15-25. PubMed ID: 3801770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes.
    Vaccari A; Gessa G
    Neurochem Res; 1989 Oct; 14(10):949-55. PubMed ID: 2532713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
    Dubocovich ML; Zahniser NR
    Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
    Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
    J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.
    Köhler C; Hall H; Ogren SO; Gawell L
    Biochem Pharmacol; 1985 Jul; 34(13):2251-9. PubMed ID: 4015674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices.
    Dyck LE; Boulton AA; Jones RS
    Eur J Pharmacol; 1980 Nov; 68(1):33-40. PubMed ID: 7449832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes.
    Del Zompo M; Piccardi MP; Ruiu S; Corsini GU; Vaccari A
    Brain Res; 1992 Feb; 571(2):354-7. PubMed ID: 1611504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters.
    Schweri MM; Skolnick P; Rafferty MF; Rice KC; Janowsky AJ; Paul SM
    J Neurochem; 1985 Oct; 45(4):1062-70. PubMed ID: 4031878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine.
    Vaccari A; Del Zompo M; Melis F; Gessa GL; Rossetti ZL
    Br J Pharmacol; 1991 Nov; 104(3):573-4. PubMed ID: 1797320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites.
    Rehavi M; Skolnick P; Brownstein MJ; Paul SM
    J Neurochem; 1982 Apr; 38(4):889-95. PubMed ID: 7062040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine.
    Vaccari A; Saba PL; Ruiu S; Collu M; Devoto P
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):102-8. PubMed ID: 8685891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
    Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
    Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum.
    Dyck LE; Juorio AV; Boulton AA
    Neurochem Res; 1982 Jun; 7(6):705-16. PubMed ID: 7121718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral cocaine receptors.
    Calligaro DO; Eldefrawi ME
    J Pharmacol Exp Ther; 1987 Oct; 243(1):61-8. PubMed ID: 2822906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lanthanides stimulate [3H]tyramine binding in the rat striatum.
    Vaccari A; Saba PL; Mocci I; Ruiu S
    Neurosci Lett; 1999 Feb; 261(1-2):49-52. PubMed ID: 10081924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of [3H]tyramine in dopaminergic and nondopaminergic brain regions.
    Vaccari A; Saba PL; Gessa GL; Del Zompo M
    J Neurochem; 1993 Feb; 60(2):758-60. PubMed ID: 8419550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine.
    Vaccari A; Saba P; Gessa G
    Neurochem Res; 1993 Nov; 18(11):1125-30. PubMed ID: 8255363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins.
    Vaccari A; Saba P
    Eur J Pharmacol; 1995 Mar; 292(3-4):309-14. PubMed ID: 7796871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.